# Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.

> **NCT05379608** · NA · COMPLETED · sponsor: **I.M. Sechenov First Moscow State Medical University** · enrollment: 43 (actual)

## Conditions studied

- COVID-19
- Chronic Heart Failure
- Hypertension
- Arrhythmia
- Conduct Disorder
- Chronic Coronary Syndrome
- Endothelial Dysfunction
- Diastolic Dysfunction
- Oxygen Consumption
- Quality of Life
- Exercise Tolerance

## Interventions

- **PROCEDURE:** Intermittent hypoxic-hyperoxic training
- **PROCEDURE:** Intermittent hypoxic-hyperoxic training/control

## Key facts

- **NCT ID:** NCT05379608
- **Lead sponsor:** I.M. Sechenov First Moscow State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-12-10
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-04-30
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05379608

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05379608, "Intermittent Hypoxic-hyperoxic Training in Patients With Cardiovascular Pathology After COVID-19 Infection.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05379608. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*